Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jointown Pharmaceutical Group Co's quarterly Other Current Payables
increased
from Sep. 2025 (¥5,581 Mil) to Dec. 2025 (¥5,956 Mil) but then
declined
from Dec. 2025 (¥5,956 Mil) to Mar. 2026 (¥5,581 Mil).
Jointown Pharmaceutical Group Co's annual Other Current Payables
increased
from Dec. 2023 (¥5,224 Mil) to Dec. 2024 (¥5,608 Mil) and
increased
from Dec. 2024 (¥5,608 Mil) to Dec. 2025 (¥5,956 Mil).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jointown Pharmaceutical Group Co Other Current Payables Chart
Jointown Pharmaceutical Group Co Other Current Payables Calculation
Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.
What does a Other Current Payables of ¥5,581 Mil mean?
Jointown Pharmaceutical Group Co (SHSE:600998) has a Other Current Payables of ¥5,581 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Jointown Pharmaceutical Group Co and its competitors.
Is Jointown Pharmaceutical Group Co's Other Current Payables too high?
Jointown Pharmaceutical Group Co's current Other Current Payables is ¥5,581 Mil. Overall, Jointown Pharmaceutical Group Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jointown Pharmaceutical Group Co's Other Current Payables compare to MCK and COR?
Jointown Pharmaceutical Group Co's Other Current Payables of ¥5,581 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Distribution company?
A good Other Current Payables depends on the Medical Distribution industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Jointown Pharmaceutical Group Co and its competitors. Jointown Pharmaceutical Group Co's current Other Current Payables is ¥5,581 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jointown Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Jointown Pharmaceutical Group Co (SHSE:600998) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥5.59, compared to a current price of ¥4.95 — trading 11.4% below its estimated fair value. The current Other Current Payables is ¥5,581 Mil. Jointown Pharmaceutical Group Co's overall GF Score™ is 83/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Jointown Pharmaceutical Group Co (SHSE:600998), the current Other Current Payables is ¥5,581 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jointown Pharmaceutical Group Co (SHSE:600998) Overvalued in 2026?
Based on GuruFocus' analysis, Jointown Pharmaceutical Group Co stock appears to be undervalued.
The current stock price of ¥4.95 is trading 11.4% below its estimated GF Value™ of ¥5.59.
GuruFocus considers Jointown Pharmaceutical Group Co to be Modestly Undervalued.
Key valuation signals for SHSE:600998:
Other Current Payables: ¥5,581 Mil
GF Value™: ¥5.59 vs. price of ¥4.95 (11.4% below fair value)
No single metric tells the full story. See the SHSE:600998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jointown Pharmaceutical Group Co Ltd is engaged in the business of wholesaling drugs and medical devices. The company offers logistics and other value-added services and mainly serves medical institutions, wholesale enterprises, and retail pharmacies.
83GF Score
Get the complete analysis for SHSE:600998
Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600998 has been successfully added to your 
